Global Percutaneous Coronary Intervention Market Growth (Status and Outlook) 2023-2029

Global Percutaneous Coronary Intervention Market Growth (Status and Outlook) 2023-2029

Percutaneous coronary intervention (PCI) is a non-surgical procedure used to treat narrowing (stenosis) of the coronary arteries of the heart found in coronary artery disease. After accessing the blood stream through the femoral or radial artery, the procedure uses coronary catheterization to visualize the blood vessels on X-ray imaging. After this, an interventional cardiologist can perform a coronary angioplasty, using a balloon catheter in which a deflated balloon is advanced into the obstructed artery and inflated to relieve the narrowing; certain devices such as stents can be deployed to keep the blood vessel open.

LPI (LP Information)' newest research report, the “Percutaneous Coronary Intervention Industry Forecast” looks at past sales and reviews total world Percutaneous Coronary Intervention sales in 2022, providing a comprehensive analysis by region and market sector of projected Percutaneous Coronary Intervention sales for 2023 through 2029. With Percutaneous Coronary Intervention sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Percutaneous Coronary Intervention industry.

This Insight Report provides a comprehensive analysis of the global Percutaneous Coronary Intervention landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Percutaneous Coronary Intervention portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Percutaneous Coronary Intervention market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Percutaneous Coronary Intervention and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Percutaneous Coronary Intervention.

The global Percutaneous Coronary Intervention market size is projected to grow from US$ 10790 million in 2022 to US$ 14340 million in 2029; it is expected to grow at a CAGR of 4.1% from 2023 to 2029.

PCI is used primarily to open a blocked coronary artery and restore arterial blood flow to heart tissue, without requiring open-heart surgery. In patients with a restricted or blocked coronary artery, PCI may be the best option to re-establish blood flow as well as prevent angina (chest pain), myocardial infarctions (heart attacks) and death. Today, PCI usually includes the insertion of stents, such as bare-metal stents, drug-eluting stents, and fully resorbable vascular scaffolds (or naturally dissolving stents).

This report presents a comprehensive overview, market shares, and growth opportunities of Percutaneous Coronary Intervention market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Coronary Stents
PTCA Catheters
Coronary Guidewires
Embolic Protection Devices

Segmentation by application
Hospitals
Healthcare Centers
ASCs

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Abbott Vascular
Svelte Medical
Medtronic
Boston Scientific
Cordis
Terumo Medical
Amg International
Asahi Intecc
B. Braun

Please note: The report will take approximately 2 business days to prepare and deliver.